BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26582827)

  • 1. Unveiling New Aspects of Meningococcal Carriage and Disease Prevention.
    Gottfredsson M
    J Clin Microbiol; 2016 Jan; 54(1):2-4. PubMed ID: 26582827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

  • 3. Meningococcal Carriage Evaluation in Response to a Serogroup B Meningococcal Disease Outbreak and Mass Vaccination Campaign at a College-Rhode Island, 2015-2016.
    Soeters HM; Whaley M; Alexander-Scott N; Kanadanian KV; MacNeil JR; Martin SW; McNamara LA; Sicard K; Vanner C; Vuong J; Wang X; Bandy U; Patel M;
    Clin Infect Dis; 2017 Apr; 64(8):1115-1122. PubMed ID: 28158417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic characterization of clonal complex sequence type 2057 (cc2057) serogroup B
    Takahashi H; Morita M; Kamiya H; Nakamura-Miwa H; Shimuta K; Ohnishi M
    J Med Microbiol; 2022 Mar; 71(3):. PubMed ID: 35238737
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimization of Molecular Approaches to Genogroup Neisseria meningitidis Carriage Isolates and Implications for Monitoring the Impact of New Serogroup B Vaccines.
    Rojas E; Hoyos J; Oldfield NJ; Lee P; Flint M; Jones CH; Ala'Aldeen DA; Jansen KU; Anderson AS
    PLoS One; 2015; 10(7):e0132140. PubMed ID: 26147212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High genomic-based predicted strain coverage among invasive meningococcal isolates when combining Bexsero and Trumenba vaccines.
    Säll O; Olofsson E; Jacobsson S
    Vaccine; 2020 Jun; 38(28):4374-4378. PubMed ID: 32414653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of
    Marshall HS; McMillan M; Koehler A; Lawrence A; MacLennan J; Maiden M; Ramsay M; Ladhani SN; Trotter C; Borrow R; Finn A; Sullivan T; Richmond P; Kahler C; Whelan J; Vadivelu K
    BMJ Open; 2019 May; 9(5):e027233. PubMed ID: 31064808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine.
    Bårnes GK; Kristiansen PA; Beyene D; Workalemahu B; Fissiha P; Merdekios B; Bohlin J; Préziosi MP; Aseffa A; Caugant DA
    BMC Infect Dis; 2016 Nov; 16(1):639. PubMed ID: 27814682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meningococcal Carriage in Military Recruits and University Students during the Pre MenB Vaccination Era in Greece (2014-2015).
    Tryfinopoulou K; Kesanopoulos K; Xirogianni A; Marmaras N; Papandreou A; Papaevangelou V; Tsolia M; Jasir A; Tzanakaki G
    PLoS One; 2016; 11(12):e0167404. PubMed ID: 27907129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolutionary and genomic insights into meningococcal biology.
    Bratcher HB; Bennett JS; Maiden MC
    Future Microbiol; 2012 Jul; 7(7):873-85. PubMed ID: 22827308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging experience with meningococcal serogroup B protein vaccines.
    Toneatto D; Pizza M; Masignani V; Rappuoli R
    Expert Rev Vaccines; 2017 May; 16(5):433-451. PubMed ID: 28375029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased genetic diversity of Neisseria meningitidis isolates after the introduction of meningococcal serogroup C polysaccharide conjugate vaccines.
    Diggle MA; Clarke SC
    J Clin Microbiol; 2005 Sep; 43(9):4649-53. PubMed ID: 16145121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unwanted guest: Neisseria meningitidis - carriage, risk for invasive disease and the impact of vaccination with insight on Italy incidence.
    Gianchecchi E; Piccini G; Torelli A; Rappuoli R; Montomoli E
    Expert Rev Anti Infect Ther; 2017 Jul; 15(7):689-701. PubMed ID: 28524748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines.
    Ladhani SN; Flood JS; Ramsay ME; Campbell H; Gray SJ; Kaczmarski EB; Mallard RH; Guiver M; Newbold LS; Borrow R
    Vaccine; 2012 May; 30(24):3710-6. PubMed ID: 22429756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of meningococcal carriage isolates from Greece by whole genome sequencing: Implications for 4CMenB vaccine implementation.
    Kesanopoulos K; Bratcher HB; Hong E; Xirogianni A; Papandreou A; Taha MK; Maiden MCJ; Tzanakaki G
    PLoS One; 2018; 13(12):e0209919. PubMed ID: 30592763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategy.
    Jeppesen CA; Snape MD; Robinson H; Gossger N; John TM; Voysey M; Ladhani S; Okike IO; Oeser C; Kent A; Oliver J; Taylor P; Morales-Aza B; Clarke SC; Casey M; Martins F; Kitchin NR; Anderson AS; Jones H; Jansen KU; Eiden J; Pedneault L; Heath PT; Finn A; Faust SN; Pollard AJ
    J Infect; 2015 Jul; 71(1):43-52. PubMed ID: 25709085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole genome typing of the recently emerged Canadian serogroup W Neisseria meningitidis sequence type 11 clonal complex isolates associated with invasive meningococcal disease.
    Tsang RSW; Ahmad T; Tyler S; Lefebvre B; Deeks SL; Gilca R; Hoang L; Tyrrell G; Van Caeseele P; Van Domselaar G; Jamieson FB
    Int J Infect Dis; 2018 Apr; 69():55-62. PubMed ID: 29414677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meningococcal vaccine development--from glycoconjugates against MenACWY to proteins against MenB--potential for broad protection against meningococcal disease.
    Dull PM; McIntosh ED
    Vaccine; 2012 May; 30 Suppl 2():B18-25. PubMed ID: 22607895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meningococcal vaccines: from polysaccharide to conjugate vaccines].
    Cohen R; Levy C
    Arch Pediatr; 2012 Sep; 19 Suppl 2():S61-4. PubMed ID: 22883368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine.
    Rossi R; Beernink PT; Giuntini S; Granoff DM
    Clin Vaccine Immunol; 2015 Dec; 22(12):1227-34. PubMed ID: 26424832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.